SC 13D

Company

UroGen Pharma Ltd.

Filed

February 15, 2018

Accession Number

0001193125-18-046992

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →